The world’s best-selling drug is in line for cheaper competition — eventually
(By Damian Garde for ST A T) T he Food and Drug Administration on Friday approved a lower-cost version of
Read moreA trusted source for Medicare news and education from the AMAC Foundation.
(By Damian Garde for ST A T) T he Food and Drug Administration on Friday approved a lower-cost version of
Read more(By Sheila Kaplan for ST A T) W ASHINGTON — A House panel investigating fetal tissue research 1 Wednesday voted
Read more(By Ed Silverman for ST A T) Y ou can add Colorado to the list of states being sued 1
Read more(By Ed Silverman for ST A T) he Food and Drug Administration on Monday approved 1 a controversial drug to
Read more(By Ed Silverman for ST A T) After weeks of deliberations, the Colombia health minister is proceeding with plans to
Read more(By Ed Silverman for ST A T) F ile this under “What were they thinking?” At a time when selling
Read more(By Ed Silverman for ST A T) I n the wake of the controversy over EpiPen pricing, 1 a group
Read more(By Ed Silverman for ST A T) P fizer won a crucial battle in its quest to widen the market
Read more(By Usha Lee McFarling for ST A T) S cientists on Monday will urge the Food and Drug Administration to
Read more(By Ike Swetlitz for ST A T) N ew York Attorney General Eric T. Schneiderman is investigating Mylan Pharmaceuticals for
Read more